Matthias Höpting

机构：University Hospital Regensburg

发表论文 7 篇 · 总被引 28 次 · h-index 3

代表论文

• Tocilizumab administration in cytokine release syndrome is associated with hypofibrinogenemia after chimeric antigen receptor T-cell therapy for hematologic malignancies (2024 · Haematologica · 被引 17)
• Platelet lipidomics indicates enhanced thrombocyte activation in patients with antiphospholipid syndrome in vivo (2025 · Journal of Thrombosis and Haemostasis · 被引 5)
• Comorbidity and adverse events in acquired hemophilia A: data from the GTH-AHA-EMI study (2024 · Research and Practice in Thrombosis and Haemostasis · 被引 4)
• Distinct Mechanisms of IgM Antibody-Mediated Acquired von Willebrand Syndrome and Successful Treatment with Recombinant von Willebrand Factor in One Patient (2022 · Acta Haematologica · 被引 3)
• Plasma lipid alterations in thrombosis and antiphospholipid syndrome—A differentiating lipid plasma composite score (2026 · Journal of Lipid Research)
• Thromboprophylaxis in pregnant Women with a History of Venous Thromboembolism and/or Thrombophilia – Demographic Data and Implementation of Pharmacological Thromboprophylaxis: Preliminary Results from a Prospective Multicenter Study in Germany (GTH VTE-PRO-PREG) (2026 · Hämostaseologie)